Saturday, April 26, 2025
HomeNews

News

Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China

Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, and TSB Therapeutics...

Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

Global Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, announced that...

FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and Caregivers

The need to diversify and strengthen the U.S. infant formula supply is more important than ever. The recent shutdown of a major infant formula...

Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston

Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced that an application for license of the manufacturing facility...

UNIPLAT by Unify Platform AG Announces Strategic Partnership with EUTECH to Spur Success of UN SDGs

UNIPLAT, the world's first online platform for researchers and entrepreneurs showcasing their research projects focused on the UN's Sustainable Development Goals (SDGs), officially announced...
0FansLike
0FollowersFollow
spot_img

Hot Topics